Adenomatous Polyposis coli Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Adenomatous Polyposis coli monoclonal antibodies for research in cellular processes. Adenomatous Polyposis coli Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Adenomatous Polyposis coli protein functions as a tumor suppressor involved in regulating cell growth and adhesion, with significant involvement in the Wnt signaling pathway. Mutations in the APC gene frequently occur in familial adenomatous polyposis and colorectal cancer, making it a crucial area of focus in cancer research. Research on Adenomatous Polyposis coli protein regulation and function continues to reveal new insights into tumorigenesis. Understanding the mechanisms of APC gene mutations helps identify potential therapeutic approaches for cancer treatment. Investigating Adenomatous Polyposis coli protein interactions advances knowledge of cellular signaling networks and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful discoveries in cancer biology and therapeutic development.